New implant offers hope for sleep apnea patients who hate CPAP

NCT ID NCT06332404

Recruiting now Disease control Sponsor: University Hospital, Antwerp Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This registry follows 225 adults with moderate-to-severe obstructive sleep apnea who receive the Inspire hypoglossal nerve stimulation implant. The device is for people who cannot use CPAP, the standard treatment. Researchers will measure how well it reduces breathing pauses during sleep and how often patients actually use it in daily life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Inspire hypoglossal nerve stimulation device
What this could lead to: If successful, this registry could confirm that the Inspire device is a safe and effective long-term option for people with sleep apnea who cannot tolerate CPAP.
What could go wrong: This is an observational registry, not a controlled trial, so results may be less definitive. The device requires surgery and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APNEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Apnea obstructive sleep apnea syndrome sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

APNEA OBSTRUCTIVE SLEEP APNEA SLEEP APNEA

Contacts and locations

Locations

AZ Sint-Jan Brugge
RECRUITING

Bruges, West-Vlaanderen, 8000, Belgium
Antwerp University Hospital
RECRUITING

Edegem, Antwerp, 2650, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.